CFGS
FLNA

Concourse Financial Group Securities’s Filana Therapeutics FLNA Stock Holding History

Concourse Financial Group Securities’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,827
Closed -$173K – 2324
2024
Q3 		$289K Buy
9,827
+3,961
+68% +$91.2K 0.02% 600
2024
Q2 		$72.4K Buy
5,866
+3,423
+140% +$72.2K ﹤0.01% 1042
2024
Q1 		$49.6K Hold
2,443
– – ﹤0.01% 1187
2023
Q4 		$55K Hold
2,443
– – ﹤0.01% 1098
2023
Q3 		$40.7K Hold
2,443
– – ﹤0.01% 1154
2023
Q2 		$59.9K Hold
2,443
– – ﹤0.01% 1029
2023
Q1 		$58.9K Hold
2,443
– – ﹤0.01% 1034
2022
Q4 		$72.2K Buy
2,443
+1,110
+83% +$39.9K 0.01% 937
2022
Q3 		$56K Hold
1,333
– – 0.01% 920
2022
Q2 		$37K Buy
+1,333
New +$33.7K ﹤0.01% 1216

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Concourse Financial Group Securities's FLNA Position: Q4 2024 in Review

Concourse Financial Group Securities sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 9,827 shares — an estimated $173K sold.

Concourse Financial Group Securities first reported a position in FLNA in Q2 2022 and held it in 10 quarters. The position peaked at $289K in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Concourse Financial Group Securities reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 9,827 Filana Therapeutics shares in Q4 2024, an estimated $173K.
  • Concourse Financial Group Securities first reported a position in Filana Therapeutics in Q2 2022 and held it in 10 quarters.
  • Concourse Financial Group Securities's Filana Therapeutics position peaked at $289K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Concourse Financial Group Securities's 13F filing for Q4 2024, filed 13 Feb 2025.